海辰药业股价涨5.62%，中欧基金旗下1只基金位居十大流通股东，持有93.7万股浮盈赚取280.16万元

Group 1 - The core viewpoint of the news is that Hainan Pharmaceutical has seen a significant increase in its stock price, rising by 5.62% to reach 56.20 yuan per share, with a trading volume of 267 million yuan and a turnover rate of 5.89%, resulting in a total market capitalization of 6.744 billion yuan [1] - Hainan Pharmaceutical, established on January 15, 2003, and listed on January 12, 2017, is primarily engaged in the research, production, and sales of chemical preparations, active pharmaceutical ingredients, and intermediates [1] - The company's main business revenue composition includes cardiovascular drugs at 87.12%, antibiotics at 5.69%, active pharmaceutical ingredients and intermediates at 1.68%, digestive drugs at 1.50%, antiviral drugs at 1.47%, and other categories [1] Group 2 - Among the top circulating shareholders of Hainan Pharmaceutical, a fund under China Europe Fund has entered the top ten, specifically the China Europe Enjoy Life Mixed A Fund (010336), which holds 937,000 shares, accounting for 1.14% of the circulating shares [2] - The China Europe Enjoy Life Mixed A Fund was established on January 7, 2021, with a latest scale of 2.048 billion yuan, achieving a year-to-date return of 12.73% and a one-year return of 10.24% [2] - The fund manager, Qian Yafengyun, has a cumulative tenure of 10 years and 96 days, with the fund's total asset scale at 2.578 billion yuan, achieving a best return of 242.9% and a worst return of -26.25% during the tenure [3]